1
|
Das J, Chauhan VD, Mills D, Johal NJ, Tan M, Matthews R, Keh R, Lilleker JB, Gosal D, Sharaf N. Therapeutic plasma exchange in neurological disorders: Experience from a tertiary neuroscience centre. Transfus Apher Sci 2019; 58:102654. [PMID: 31648858 DOI: 10.1016/j.transci.2019.09.007] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2019] [Revised: 08/13/2019] [Accepted: 09/27/2019] [Indexed: 10/25/2022]
Abstract
Therapeutic plasma exchange (TPE) involves the extracorporeal separation of plasma from the cellular components of blood with replacement fluid, such as human albumin or fresh frozen plasma. A number of studies across the world revealed that more than one third of TPE procedures were performed for neurological disorders. Myasthenia gravis (MG), Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) were the most frequently cited indications for TPE, followed by multiple sclerosis (MS). However, treatments of these conditions have evolved over the years and it is likely that this has impacted on clinical practice. Here we present our experience of using TPE to treat neurological disorders. We reviewed the medical records of all 63 patients who received 349 procedures over 70 therapeutic cycles between 2012 and 2015 in a tertiary neurology centre. In total only 2 patients with GBS and MG were treated with TPE. The commonest indication was voltage gated potassium channel (VGKC) complex antibody associated disorders followed by CIDP and MS. There were 11 patients with limbic encephalitis. Nine of them had antibodies against VGKC complex and two had N-methyl-D-aspartate (NMDA) receptor antibodies. Sixty four percent of patients with limbic encephalitis and overall 78% of patients responded to TPE. The complication rate associated with this procedure was 8.6 per 100 therapeutic cycle. There was no treatment related mortality. We observed a change in indications of TPE compared to historical studies. It was less frequently used to treated GBS and MG. It was found to be safe and effective.
Collapse
Affiliation(s)
- Joyutpal Das
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK.
| | - Vanisha D Chauhan
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK.
| | - Daniel Mills
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| | - Nicholas J Johal
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| | - Maevis Tan
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| | - Rachael Matthews
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| | - Ryan Keh
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| | - James B Lilleker
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK; Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, M13 9PT, UK
| | - David Gosal
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| | - Nazar Sharaf
- Clinical Neurosciences, Manchester Academic Health Science Centre, Salford Royal NHS Foundation Trust, Stott Lane, Salford, M6 8HD, UK
| |
Collapse
|
3
|
Li Z, Teng B, Luo J, Zhao J. Clinical application of therapeutic plasma exchange in the Three Gorges Area. Transfus Apher Sci 2010; 43:305-308. [PMID: 20961812 DOI: 10.1016/j.transci.2010.09.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
OBJECTIVE To analyze the clinical effect of therapeutic plasma exchange (TPE) on 43 patients in the Three Gorges Area. METHODS Plasma was collected by machine and combined with low-molecular-weight dextran and albumin for use as a replacement fluid for TPE treatment of 43 patients suffering from various blood disorders, diseases of the nervous system, ABO incompatible allogeneic hematopoietic stem cell transplantation and kidney disease. RESULTS The volume of a single TPE was 1.6-2.0l, performed on average 2.3 times/case, and effective in 88.4% (38/43) of cases. CONCLUSION TPE through the plasma collection machine is a well tolerated, economic and effective treatment.
Collapse
Affiliation(s)
- Zhongjun Li
- Department of Blood Transfusion, XinQiao Hospital, Third Military Medical University, Chongqing 400037, China.
| | - Benxiu Teng
- Department of Blood Transfusion, XinQiao Hospital, Third Military Medical University, Chongqing 400037, China
| | - Juan Luo
- Department of Blood Transfusion, XinQiao Hospital, Third Military Medical University, Chongqing 400037, China
| | - Jiang Zhao
- Department of Blood Transfusion, XinQiao Hospital, Third Military Medical University, Chongqing 400037, China
| |
Collapse
|